Question special
Resident

When assessing the primary endpoint of stimulant abstinence, which you defined as "three methamphetamine-negative urine samples”, would self-reported decrease of cravings and frequency of use be sensitive measures?  When considering clinically relevant results, what other variables would you consider as potential outcome markers?